Vetoquinol SA
PAR:VETO

Watchlist Manager
Vetoquinol SA Logo
Vetoquinol SA
PAR:VETO
Watchlist
Price: 76.6 EUR 0.26% Market Closed
Market Cap: 910m EUR
Have any thoughts about
Vetoquinol SA?
Write Note

Vetoquinol SA
Investor Relations

Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Alain Masson
Deputy CEO & Pharmacist Manager
No Bio Available
Mr. Matthieu Frechin
CEO & Non-Independent Chairman of the Board
No Bio Available
Mr. Regis Vimal du Monteil
Chief Financial Officer
No Bio Available
Mr. Dominique Derveaux
Chief Operations Officer
No Bio Available
Philippe Gruet
Chief Scientific Officer
No Bio Available
Sandrine Perrier
Chief Information Officer
No Bio Available
Laurent Thore
Director of Partnerships, Legal Affairs & Risks
No Bio Available
Xavier Berthet
Director of Group Communications
No Bio Available
Ms. Isabelle Proust-Cabrera
Group Director of Human Resources
No Bio Available

Contacts

Address
BOURGOGNE-FRANCHE-COMTE
Lure
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
Contacts
+33384625555.0
www.vetoquinol.com